The concentrations of cefoxitin in serum and cerebrospinal fluid (CSF) were measured simultaneously in three groups of patients, 12 with aseptic meningitis (group 1) and 17 and 14 with bacterial meningitis (groups 2 and 3). The patients in group 1 received a single intravenous dose of 2 g of cefoxitin without other antimicrobial therapy. In addition to conventional doses of ampicillin or benzyl penicillin, patients in groups 2 and 3 received repeated infusions of 2 g of cefoxitin every 4 h for the first 3 or 4 days of the study and again on day 10. Additionally, group 3 received probenecid in a loading dose of 1 g followed by 0.5 g every 6 or 8 h. Concentrations of cefoxitin in CSF and serum were determined 1 or 2 h after infusion in group 2 and 2 h after infusion in group 3. The concentrations of cefoxitin in CSF did not reach detectable levels (1.56 ,ug/ml) in 11 of the 12 patients in group 1. A level of 2.8 jig of cefoxitin per ml of CSF was found, with an accompanying level of 30 ,ug/ml of serum, in patient 12. In the group 2 patients with bacterial meningitis, the mean CSF concentrations were 3.3, 4.7, and 2.9,g/ ml on days 1, 3, and 10 of treatment, with simultaneous serum levels of 8, 9, and 8 ,tg/ml. At similar times periods, the mean levels of cefoxitin in group 3 patients (with concomitant probenecid) were 8.6, 12.3, and 4.3 ,ug/ml of CSF and 57, 35, 27
,ug/ml of serum.
Although most cephalosporins have significant activity against Escherichia coli and Klebsiella sp. in vitro, they have not been especially effective against meningeal infections with these organisms. The lack of effectiveness of some of these antibiotics may be attributed to irregular penetration of the cerebrospinal fluid (CSF) or failure to penetrate in concentrations needed to inhibit growth'of the infecting bacteria (1, 2, 3, 6, 11) . Not all cephalosporins share these qualities. Studies in animals and humans have shown that cephaloridine, cefamandole (10, 12) , and cefoxitin (5, 7, 8) enter the CSF in concentrations which should inhibit or kill most strains of E. coli and Kleb iella. To date, treatment of meningitis with cefamandole has been disappointing (13) . Results obtained with cefoxitin have been more encouraging, although the number of cases has been small (7, 8 Table 2 ). There were 12 patients with nonbacterial meningitis in group 1, 11 with an "aseptic meningitis" of unknown etiology, and 1 with a parameningeal focus of infection with signs of moderate inflammation in the CSF. CSF was collected from these patients via lumbar puncture 1 or 2 h after administration of 2 g of cefoxitin in a 30-min infusion.
There were 17 patients with bacterial meningitis (mainly meningococcal) in group 2 undergoing treatment with 12 g of ampicillin of 20 x 106 U of intravenous penicillin per day divided into infusions given every 4 h. Two grams of cefoxitin in 30-min infusions were given to these patients, and CSF was collected 2 or 3 h after the infusion. The infusions of penicillin or ampicillin and cefoxitin were given in sequence, one after the other. In general, penicillin or ampicillin was started from 8 to 12 h before the start of cefoxitin. The first lumbar puncture was obtained within 24 h of the diagnostic lumbar puncture and 2 or 3 h after the first infusion of cefoxitin. The second CSF sample was taken on day 3 (Table 1) .
The cefoxitin concentrations in the CSF of group 3 patients were 8.6, 12.3, and 4.3 ug/ml on days 1, 3, and 10 of treatment (Table 2) . Serum levels in group 3 patients at the end of the infusions were no higher than those in group 2, but the levels at 2 h were much higher: 57, 35, and 27 ,ug/ml, respectively. Thus, between 15 and 35% of the serum level was present in the CSF. The difference in CSF concentrations due to the addition of probenecid can be illustrated by a patient who suffered recurrent bacterial meningitis secondary to a meningeal CSF leak. This patient was a member of group 2 for the first episode and group 3 for the second. The CSF concentrations were 1.6, 3.5, and 2.5 ,ug/ml while in group 2, and 2.6, 6.2, and 2.5 ,ug/ml with probenecid while in group 3.
Neither the CSF cell count, protein or glucose value, nor renal function showed a clear linear association with spinal fluid concentrations, although the lowest levels, in general, were found in the third sample, at the end of treatment, when the signs of meningeal inflamtion had nearly disappeared and the cell count, CSF protein, and glucose were in some cases normal. In several cases this was not the lowest concentration detected, indicating the large amount of variability of the results obtained. The age of the patient had the closest relationship to elevated CSF levels: patients 11, 12, 16, and 17 (Table 1) in group 2 were 4 of the oldest patients among the 17; patients 11 through 14 (Table 2) were by far the oldest patients in group 3. All had at least a minimal degree of renal insufficiency at the beginning of treatment ( With the administraton of 12 g of cefoxitin and 1.5 to 2 g of probenecid per day, CSF levels that exceed minimum inhibitory and minimum bactericidal concentrations of virtually all clinical E. coli, Klebsiella, and Proteus isolates can be achieved regularly (4) . Since levels are highest in middle-aged and elderly patients, the population that is afflicted by this entity, who may have in addition a relative degree of renal insufficiency (certainly as compared with younger patients), cefoxitin and probenecid would appear to be a therapy worth consideration in the treatment of gram-negative meningitis.
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